NEFL and Alzheimer disease: Longitudinal alterations in plasma p-tau181 and plasma neurofilament light chain levels were related to prospective neurodegeneration and cognitive decline and can support monitoring of disease progression in AD, as was provided by a recent study with participants from the multi-centric Alzheimer’s Disease Neuroimaging Initiative study [27].